[1
]
From the Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen; Department
of Rheumatology, Zealand's University Hospital, Køge, Denmark; Dipartimento Scienze
Cliniche e Biologiche - Reumatologia, Università degli Studi di Torino, Turin; Department
of Medicine, Surgery and Neurosciences, Rheumatology Section, University of Siena,
Siena; Pediatric Rheumatology Unit, IRCCS Ospedale Pediatrico Bambino Gesù, Rome;
Internal Medicine Department, Azienda Socio Sanitaria Territoriale di Mantova, C.
Poma Hospital, Mantua, Italy; Department of Rheumatology, MC Groep, Lelystad; Department
of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Department
of Rheumatology, Joint and Bone Research Unit, Hospital Universitario Fundación Jiménez
Díaz; Autónoma University; Hospital Universitario Severo Ochoa, Madrid, Spain; Clinic
Center, Faculty of Medicine, University of Niš, Niš; Institute of Rheumatology, Faculty
of Medicine, University of Belgrade, Belgrade, Serbia; Rheumatology Research Group,
The University of Birmingham, Birmingham; Leeds Institute of Rheumatic and Musculoskeletal
Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds
Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Leeds, UK; Department
of Rheumatology and Clinical Immunology, Faculty of Medicine, University of Freiburg,
Freiburg; Charite University Hospital, Humboldt University; Immanuel Krankenhaus Berlin,
Medical Center for Rheumatology Berlin-Buch; Pediatric Rheumatology Research Institute,
Bad Bramstedt, Germany; APHP, Department of Rheumatology, CHU Pitie-Salpetriere, Paris
6 University, GRC-UPMC 08, Pierre Louis Institute of Epidemiology and Public Health;
APHP, Hôpital Ambroise Paré, Rheumatology Department, 92100 Boulogne-Billancourt;
INSERM U1173, Laboratoire d'Excellence INFLAMEX, UFR Simone Veil, Versailles-Saint-Quentin
University, 78180 Saint-Quentin en Yvelines, Paris, France; Department of Allergy
and Clinical Immunology, Chiba University Hospital, Chiba, Japan; Department of Rheumatology,
Royal Perth Hospital, Perth, Australia; Instituto Nacional de Rehabilitacion, Mexico
City, Mexico; Rheumatology Institute of Rheumatology and Orthopedics, Royal Prince
Alfred Hospital, Camperdown, Australia; Department of Rheumatology, Université catholique
de Louvain, Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires
Saint Luc, Brussels, Belgium. As part of the supplement series OMERACT 13, this report
was reviewed internally and approved by the Guest Editors for integrity, accuracy,
and consistency with scientific and ethical standards. L. Terslev, MD, PhD, Center
for Rheumatology and Spine Diseases, Rigshospitalet; A. Iagnocco, MD, Dipartimento
Scienze Cliniche e Biologiche - Reumatologia, Università degli Studi di Torino; G.A.
Bruyn, MD, PhD, Department of Rheumatology, MC Groep; E. Naredo, MD, Department of
Rheumatology, Joint and Bone Research Unit, Hospital Universitario Fundación Jiménez
Díaz, and Autónoma University; J. Vojinovic, MD, PhD, Clinic Center, Faculty of Medicine,
University of Niš; P. Collado, MD, Hospital Universitario Severo Ochoa; N. Damjanov,
MD, PhD, Institute of Rheumatology, Faculty of Medicine, University of Belgrade; A.
Filer, MD, PhD, Rheumatology Research Group, The University of Birmingham; G. Filippou,
MD, Department of Medicine, Surgery and Neurosciences, Rheumatology Section, University
of Siena; S. Finzel, MD, Department of Rheumatology and Clinical Immunology, Faculty
of Medicine, University of Freiburg; F. Gandjbakhch, MD, APHP, Department of Rheumatology,
CHU Pitie-Salpetriere, Paris 6 University, GRC-UPMC 08, Pierre Louis Institute of
Epidemiology and Public Health; K. Ikeda, MD, PhD, Department of Allergy and Clinical
Immunology, Chiba University Hospital; H.I. Keen, MD, PhD, Department of Rheumatology,
Royal Perth Hospital; M.C. Kortekaas, MD, PhD, Department of Rheumatology, Leiden
University Medical Center; S. Magni-Manzoni, MD, Pediatric Rheumatology Unit, IRCCS
Ospedale Pediatrico Bambino Gesù; S. Ohrndorf, MD, Charite University Hospital, Humboldt
University; C. Pineda, MD, Research Directorate, Instituto Nacional de Rehabilitacion;
V. Ravagnani MD, PhD, Internal Medicine Department, Azienda Socio Sanitaria Territoriale
di Mantova, C. Poma Hospital; B. Richards, MD, Rheumatology Institute of Rheumatology
and Orthopedics, Royal Prince Alfred Hospital; I. Sahbudin, MD, Rheumatology Research
Group, The University of Birmingham; W.A. Schmidt, MD, Immanuel Krankenhaus Berlin,
Medical Center for Rheumatology Berlin-Buch; H.J. Siddle, MSc, PhD, Leeds Institute
of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Musculoskeletal
Biomedical Research Unit, Chapel Allerton Hospital; M.S. Stoenoiu, MD, PhD, Department
of Rheumatology, Université catholique de Louvain, Institut de Recherche Expérimentale
et Clinique, Cliniques Universitaires Saint Luc; M. Szkudlarek, MD, PhD, Department
of Rheumatology, Zealand's University Hospital at Køge; N. Tzaribachev, MD, Pediatric
Rheumatology Research Institute; M.A. D'Agostino, MD, PhD, APHP, Hôpital Ambroise
Paré, Rheumatology Department, 92100 Boulogne- Billancourt, and INSERM U1173, Laboratoire
d'Excellence INFLAMEX, UFR Simone Veil, Versailles-Saint-Quentin University. Address
correspondence to Dr. L. Terslev, Rigshospitalet Glostrup, Center for Rheumatology
and Spine Disease, Ndr. Ringvej 57, Glostrup, 2600, Denmark. E-mail: terslev@dadlnet.dk.